Grace Colón
About
Grace Colón is from Los Gatos, California, United States. Grace is currently undefined at undefined. Grace also works as Chair, Board of Directors at Aronora, a job Grace has held since Aug 2025. Another title Grace currently holds is Strategic Advisor at EOLO PHARMA. In Grace's previous role as a Board Of Directors at CareDx, Inc., Grace worked in Brisbane, California until Jun 2024.
You can find Grace Colon's email address at finalscout.com. FinalScout is a free professional database with over five hundred million business professional profiles and over two hundred million company profiles.
Grace Colón's current jobs
Aronora is a clinical-stage biopharmaceutical company pioneering innovative therapies for cardio-hematologic diseases. The company is advancing a robust pipeline of clinical programs grounded in decades of scientific thought leadership and aiming to meaningfully improve patient outcomes.
Eolo Pharma is a clinical-stage biotechnology company pioneering new approaches to treat obesity and metabolic disease. By targeting the body’s energy expenditure pathways, Eolo aims to develop transformative therapies that go beyond traditional weight-loss mechanisms. The lead program, MVD-1, is an oral, first-in-class NCE that targets the body’s natural energy-burning system through a newly druggable pathway: creatine-dependent thermogenesis.
Bloom Science is a clinical-stage, central nervous system (CNS) company, trailblazing a path using novel microbiome approaches to develop transformative, novel therapeutics for patients with rare and complex neurological disorders. The company is advancing a deep pipeline of programs in obesity, Dravet syndrome and other rare epilepsies; Amyotrophic Lateral Sclerosis (ALS), and others.
Emm is developing a new platform for smart menstrual care and personalized health insights for women. The first product offering includes a menstrual cup with integrated sensors to precisely quantify menstrual metrics including volume, frequency and duration of bleeding, paired with a charging device, tracking app and more, with a commercial launch in the UK planned in 2026. The platform will enable new research in fundamental biology, novel diagnostics and therapeutics, and informative insights for patients and clinicians.
Voyager Therapeutics (NASDAQ:VYGR) is leveraging its expertise in neuroscience and its pioneering discoveries in AAV capsids to advance life-changing gene therapies and other therapeutic modalities for neurological diseases. Member of Compensation and Audit Committees.
The Biotech CEO Sisterhood is a vibrant community dedicated to championing the success of women leaders in the biopharma industry. Rooted in a culture of mutual support and authenticity, the Sisterhood aims to inspire and uplift women while driving meaningful conversations and impact across the industry. As part of our commitment to nurturing the current and future generations of biotech leaders, the Sisterhood hosts summits, local events, and educational sessions. These programs encourage dialogue about the challenges facing women in biotech, share best practices, and enhance leadership effectiveness. Editorial Board member of the Biotech CEO Sisterhood channel on Biotech TV; regularly interview leading CEOs.
Served as an elected member of the Board of the MIT Corporation for a 5-yr term (MIT's Board of Trustees; 2021-2026). Currently serving as a member of the Corporation Visiting Committee of the Institute for Data, Systems, and Society (served as Chair of the Visiting Committee from 2023-2026). From 2021-2026 served as member of the Chemical Engineering and Biological Engineering Visiting Committees. Standing Committee: Corporation Joint Advisory Committee on Institute-Wide Affairs (2022-2024). Corporation Advisory Committee on DEI
2021 - Present - Member of Emerging Companies Section June 2023 - June 2025: Vice Chair, Emerging Companies Section; member, BIO Board Executive Committee; member, ECS Executive Committee 2022-2023 - Member of Emerging Companies Section Executive Committee; Co-Chair, ECS Strategy and Policy Committee
Grace Colón's past jobs
CareDx (NASDAQ:CDNA) is a leading molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients. Compensation Committee (Member); Science and Technology Committee (Chair).